Yong-ping Zhai
Nanjing, 210002, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Correlation of IgG Levels at Initial Diagnosis with Clinical Efficacy and Prognosis in 66 Patients with IgG Multiple Myeloma
Journal: Zhongguo shi yan xue ye xue za zhi
Published: August 17, 2019
Cost-Effectiveness Analysis of Different Chemotherapy Regimens in the Treatment of Patients with Multiple Myeloma
Journal: Zhongguo shi yan xue ye xue za zhi
Published: June 29, 2018
Effect and Clinical Significance of Bortezomib and Thalidomide on the Memory T Cells Subsets and Regulatory T Cells in Peripheral Blood of Patients with Multiple Myeloma
Journal: Zhongguo shi yan xue ye xue za zhi
Published: April 19, 2018
Establishment and Management of Multiple Myeloma Specimen Bank Applied for Molecular Biological Researches
Journal: Zhongguo shi yan xue ye xue za zhi
Published: December 22, 2017
Research Progress on Molecular Mechanisms of Resistance to Bortezomib in Multiple Myeloma- Review
Journal: Zhongguo shi yan xue ye xue za zhi
Published: October 27, 2017
Acute Promyelocytic Leukemia Developed during Imatinib Therapy for Gastrointestinal Stromal Tumors
Journal: Zhongguo shi yan xue ye xue za zhi
Published: April 28, 2017
Clinical and Immunophenotypic Properties of Small Cell Variant of T-cell Prolymphocytic Leukemia
Journal: Zhongguo shi yan xue ye xue za zhi
Published: March 01, 2017
Clinico-pathologic Characteristics of Adult Patients with Atypical Infectious Mononucleosis
Journal: Zhongguo shi yan xue ye xue za zhi
Published: December 28, 2016
Application Value of CD138 MACS-FISH in the Genetic Diagnosis of Plasma Cell Dyscrasia
Journal: Zhongguo shi yan xue ye xue za zhi
Published: October 28, 2016
Clinicopathologic Characteristics and Outcome of Isolated Ovarian Relapse in Adolescent with Acute Lymphoblastic Leukemia
Journal: Zhongguo shi yan xue ye xue za zhi
Published: October 28, 2016
Activity of fibroblast growth factor receptor inhibitors TKI258, ponatinib and AZD4547 against TPR‑FGFR1 fusion.
Journal: Molecular medicine reports
Published: November 19, 2015
Last Updated: 09/26/2026